ARTICLE | Clinical News

Amgen Inc. (AMGN) preclinical data

July 31, 1995 7:00 AM UTC

Amgen researchers published studies in mice that show the ob gene product can reverse the obesity and metabolic defects present with the mutated gene. As reported in Science, the human ob gene product also was effective in correcting the gene defect in mice. ...